These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12753507)

  • 1. Increased brain-derived neurotrophic factor expression in white blood cells of relapsing-remitting multiple sclerosis patients.
    Gielen A; Khademi M; Muhallab S; Olsson T; Piehl F
    Scand J Immunol; 2003 May; 57(5):493-7. PubMed ID: 12753507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune cell NT-3 expression is associated with brain atrophy in multiple sclerosis patients.
    Kalinowska-Łyszczarz A; Pawlak MA; Michalak S; Paprzycki W; Losy J
    J Neuroimmunol; 2011 Dec; 240-241():109-13. PubMed ID: 22036954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulated neurotrophin mRNA production by immune cells of patients with relapsing remitting multiple sclerosis.
    Urshansky N; Mausner-Fainberg K; Auriel E; Regev K; Farhum F; Karni A
    J Neurol Sci; 2010 Aug; 295(1-2):31-7. PubMed ID: 20541775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotrophic factors and clinical recovery in relapsing-remitting multiple sclerosis.
    Caggiula M; Batocchi AP; Frisullo G; Angelucci F; Patanella AK; Sancricca C; Nociti V; Tonali PA; Mirabella M
    Scand J Immunol; 2005 Aug; 62(2):176-82. PubMed ID: 16101825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A longitudinal observation of brain-derived neurotrophic factor mRNA levels in patients with relapsing-remitting multiple sclerosis.
    Liguori M; Fera F; Patitucci A; Manna I; Condino F; Valentino P; Telarico P; Cerasa A; Gioia MC; di Palma G; Quattrone A
    Brain Res; 2009 Feb; 1256():123-8. PubMed ID: 19071096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of neurotrophic factors and inflammatory cytokines by myelin basic protein-specific and other recruited T cells infiltrating the central nervous system during experimental autoimmune encephalomyelitis.
    Muhallab S; Lundberg C; Gielen AW; Lidman O; Svenningsson A; Piehl F; Olsson T
    Scand J Immunol; 2002 Mar; 55(3):264-73. PubMed ID: 11940233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The balance of pro-inflammatory and trophic factors in multiple sclerosis patients: effects of acute relapse and immunomodulatory treatment.
    Lindquist S; Hassinger S; Lindquist JA; Sailer M
    Mult Scler; 2011 Jul; 17(7):851-66. PubMed ID: 21561957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-cell BDNF expression in treatment-naïve relapsing-remitting multiple sclerosis patients and following one year of immunomodulation therapy.
    Kalinowska-Łyszczarz A; Pawlak MA; Wyciszkiewicz A; Osztynowicz K; Kozubski W; Michalak S
    Neurol Neurochir Pol; 2018 Aug; 52(4):483-489. PubMed ID: 29643001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-beta 1a, and high doses of immunoglobulins.
    Sarchielli P; Zaffaroni M; Floridi A; Greco L; Candeliere A; Mattioni A; Tenaglia S; Di Filippo M; Calabresi P
    Mult Scler; 2007 Apr; 13(3):313-31. PubMed ID: 17439900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Increase expression of neurotrophins mRNA in peripheral blood of patients with allergic rhinitis].
    Chen R; Wang H; Zhong Y; Geng Y; Xu C; Kang W; Lin Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Mar; 28(5):308-10. PubMed ID: 25185284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: reversal by glatiramer acetate.
    Azoulay D; Vachapova V; Shihman B; Miler A; Karni A
    J Neuroimmunol; 2005 Oct; 167(1-2):215-8. PubMed ID: 16083971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of IL-15 mRNA in relapsing--remitting multiple sclerosis attacks.
    Blanco-Jerez C; Plaza JF; Masjuan J; Orensanz LM; Alvarez-Cermeño JC
    J Neuroimmunol; 2002 Jul; 128(1-2):90-4. PubMed ID: 12098515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy.
    Caggiula M; Batocchi AP; Frisullo G; Angelucci F; Patanella AK; Sancricca C; Nociti V; Tonali PA; Mirabella M
    Clin Immunol; 2006 Jan; 118(1):77-82. PubMed ID: 16275091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced production of noggin by immune cells of patients with relapsing-remitting multiple sclerosis.
    Urshansky N; Mausner-Fainberg K; Auriel E; Regev K; Bornstein NM; Karni A
    J Neuroimmunol; 2011 Mar; 232(1-2):171-8. PubMed ID: 21111488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations between peripheral blood mononuclear cell production of BDNF, TNF-alpha, IL-6, IL-10 and cognitive performances in multiple sclerosis patients.
    Patanella AK; Zinno M; Quaranta D; Nociti V; Frisullo G; Gainotti G; Tonali PA; Batocchi AP; Marra C
    J Neurosci Res; 2010 Apr; 88(5):1106-12. PubMed ID: 19885866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of combined exercise training on serum brain-derived neurotrophic factor, suppressors of cytokine signaling 1 and 3 in patients with multiple sclerosis.
    Ozkul C; Guclu-Gunduz A; Irkec C; Fidan I; Aydin Y; Ozkan T; Yazici G
    J Neuroimmunol; 2018 Mar; 316():121-129. PubMed ID: 29329698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The IFN-β 1b effect on Cu Zn superoxide dismutase (SOD1) in peripheral mononuclear blood cells of relapsing-remitting multiple sclerosis patients and in neuroblastoma SK-N-BE cells.
    Damiano S; Sasso A; De Felice B; Terrazzano G; Bresciamorra V; Carotenuto A; Orefice NS; Orefice G; Vacca G; Belfiore A; Santillo M; Mondola P
    Brain Res Bull; 2015 Sep; 118():1-6. PubMed ID: 26327496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity.
    Rieckmann P; Albrecht M; Kitze B; Weber T; Tumani H; Broocks A; Lüer W; Helwig A; Poser S
    Ann Neurol; 1995 Jan; 37(1):82-8. PubMed ID: 7818262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-derived neurotrophic factor in patients with multiple sclerosis.
    Sarchielli P; Greco L; Stipa A; Floridi A; Gallai V
    J Neuroimmunol; 2002 Nov; 132(1-2):180-8. PubMed ID: 12417449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical role for expression of atypical chemokine receptor 2 in multiple sclerosis: A preliminary project.
    Saçmacı H; Sabah Özcan S
    Mult Scler Relat Disord; 2020 Feb; 38():101524. PubMed ID: 31770664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.